Baltimore Capital Management’s Pfizer PFE Stock Holding History

Baltimore Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$368K	Buy	+9,123	New	+$365K	0.6%	48
2018 Q3	$381K	Sell	9,123 -791	-8%	-$30.5K	0.61%	47
2018 Q2	$341K	Hold	9,914	–	–	0.51%	53
2018 Q1	$334K	Hold	9,914	–	–	0.5%	52
2017 Q4	$341K	Sell	9,914 -422	-4%	-$14.4K	0.48%	53
2017 Q3	$350K	Hold	10,336	–	–	0.49%	51
2017 Q2	$329K	Buy	10,336 +211	+2%	+$6.65K	0.48%	49
2017 Q1	$329K	Buy	+10,125	New	+$319K	0.44%	51

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baltimore Capital Management's PFE Position: Q1 2019 in Review

Baltimore Capital Management opened a new position in Pfizer (PFE) in Q1 2019: 9,123 shares worth $368K. The stake represents 0.6% of the portfolio and ranks #48 among its holdings. This is a return to the name: Baltimore Capital Management previously reported a position in PFE as recently as Q3 2018.

Baltimore Capital Management first reported a position in PFE in Q1 2017 and has held it in 8 quarters since. The position peaked at $381K in Q3 2018. 2,391 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

Baltimore Capital Management held 9,123 shares of Pfizer worth $368K as of Q1 2019.
Pfizer was a new Baltimore Capital Management position in Q1 2019.
Pfizer made up 0.6% of Baltimore Capital Management's portfolio in Q1 2019, its #48 holding.
Baltimore Capital Management first reported a position in Pfizer in Q1 2017 and has held it in 8 quarters since.
Baltimore Capital Management's Pfizer position peaked at $381K in Q3 2018.
2,391 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on Baltimore Capital Management's 13F filing for Q1 2019, filed 14 May 2019.